Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bausch Health Companies Inc BHC


Primary Symbol: T.BHC

Healthcare
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with... see more

Recent & Breaking News (TSX:BHC)

Bausch Health Provides Preliminary Update On Fourth-Quarter And Full-Year 2020 Financial Results And Business Recovery

Canada NewsWire January 12, 2021

Bausch Health To Participate At The 39th Annual J.P. Morgan Healthcare Conference

Canada NewsWire January 6, 2021

Bausch Health's DEXAVEN (Dexamethasone Phosphate) Receives New Indication In Poland To Treat Patients With SARS-CoV-2 (COVID-19)

Canada NewsWire December 30, 2020

Bausch Health To Reduce Debt By $275 Million

Canada NewsWire December 29, 2020

Bausch + Lomb Announces Additional Expanded Public Coverage for (Pr)VYZULTA® (Latanoprostene Bunod Ophthalmic Solution 0.024% w/w) in Canada

Canada NewsWire December 1, 2020

Bausch Health Initiates Second Phase 3 Study For NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction

Canada NewsWire November 24, 2020

Bausch Health Announces Pricing And Upsize Of Private Offering Of Senior Notes And Conditional Redemption Of Additional Series Of Existing Senior Notes

Canada NewsWire November 18, 2020

Bausch Health Announces Launch Of Private Offering Of Senior Notes And Conditional Redemption Of Existing Senior Notes

Canada NewsWire November 18, 2020

Bausch Health Announces Investigational In Vitro Data Indicating Complete Inactivation Of SARS-CoV-2 With LUMIFY® And BESIVANCE® Eye Drops Preserved With Benzalkonium Chloride

PR Newswire November 16, 2020

Sol-Gel Technologies Reports Third Quarter 2020 Financial Results and Corporate Update

GlobeNewswire November 12, 2020

Bausch + Lomb Reports Nearly 27 Million Units of Contact Lens Materials Recycled Through One By One Recycling Program

Canada NewsWire November 12, 2020

Salix To Present Data At AASLD's The Liver Meeting Digital Experience

PR Newswire November 11, 2020

Bausch Health Announces Participation In Upcoming Investor Conferences

Canada NewsWire November 10, 2020

Bausch Health, Canada Receives a Positive Recommendation from the CADTH Canadian Drug Expert Committee (CDEC) for DUOBRII(TM) - a Novel Topical Antipsoriatic Prescription Drug

Canada NewsWire November 10, 2020

Bausch Health Companies Inc. Announces Third-Quarter 2020 Results

Canada NewsWire November 3, 2020

Bausch Health's Rifaximin Receives FDA Orphan Designation For Sickle Cell Disease

Canada NewsWire October 29, 2020

Bausch Health To Reduce Debt By $150 Million Using Cash Generated From Operations

Canada NewsWire October 29, 2020

Bausch + Lomb Introduces SimplifEYE(TM) IOL Delivery System For enVista® Toric And Monofocal Preloaded Intraocular Lenses

Canada NewsWire October 27, 2020

Ortho Dermatologics To Present New Analyses At The Virtual Fall Clinical Dermatology Conference

Canada NewsWire October 26, 2020

Salix To Present Data For Products Across Its Portfolio At The American College Of Gastroenterology 2020 Virtual Annual Meeting

Canada NewsWire October 22, 2020